Logo image of MGN.OL

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

OSL:MGN - Euronext Oslo - NO0010187032 - Common Stock - Currency: NOK

22.35  +0.3 (+1.36%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MGN. MGN was compared to 22 industry peers in the Independent Power and Renewable Electricity Producers industry. While MGN has a great health rating, its profitability is only average at the moment. MGN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MGN was profitable.
MGN had positive earnings in 4 of the past 5 years.
In multiple years MGN reported negative operating cash flow during the last 5 years.
MGN.OL Yearly Net Income VS EBIT VS OCF VS FCFMGN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

MGN's Return On Assets of 95.90% is amongst the best of the industry. MGN outperforms 100.00% of its industry peers.
The Return On Equity of MGN (129.55%) is better than 100.00% of its industry peers.
The Return On Invested Capital of MGN (40.57%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 95.9%
ROE 129.55%
ROIC 40.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MGN.OL Yearly ROA, ROE, ROICMGN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

MGN has a better Profit Margin (11786.27%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of MGN has grown nicely.
MGN has a better Operating Margin (4870.59%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of MGN has grown nicely.
Industry RankSector Rank
OM 4870.59%
PM (TTM) 11786.27%
GM N/A
OM growth 3YN/A
OM growth 5Y181.44%
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
MGN.OL Yearly Profit, Operating, Gross MarginsMGN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

7

2. Health

2.1 Basic Checks

MGN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MGN.OL Yearly Shares OutstandingMGN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MGN.OL Yearly Total Debt VS Total AssetsMGN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

There is no outstanding debt for MGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC4.82
WACC8.41%
MGN.OL Yearly LT Debt VS Equity VS FCFMGN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MGN has a Current Ratio of 2.37. This indicates that MGN is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.37, MGN is doing good in the industry, outperforming 72.73% of the companies in the same industry.
MGN has a Quick Ratio of 2.37. This indicates that MGN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.37, MGN is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
MGN.OL Yearly Current Assets VS Current LiabilitesMGN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

MGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.39%, which is quite impressive.
The Earnings Per Share has been growing by 87.45% on average over the past years. This is a very strong growth
The Revenue for MGN has decreased by -94.94% in the past year. This is quite bad
MGN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.96% yearly.
EPS 1Y (TTM)101.39%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%1519.54%
Revenue 1Y (TTM)-94.94%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%6503.35%

3.2 Future

MGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.60% yearly.
Based on estimates for the next years, MGN will show a very negative growth in Revenue. The Revenue will decrease by -24.73% on average per year.
EPS Next Y-48.07%
EPS Next 2Y10.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-26.54%
Revenue Next 2Y21.48%
Revenue Next 3Y-24.73%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MGN.OL Yearly Revenue VS EstimatesMGN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MGN.OL Yearly EPS VS EstimatesMGN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.31 indicates a rather cheap valuation of MGN.
Compared to the rest of the industry, the Price/Earnings ratio of MGN indicates a rather cheap valuation: MGN is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MGN to the average of the S&P500 Index (29.35), we can say MGN is valued rather cheaply.
The Price/Forward Earnings ratio is 7.76, which indicates a rather cheap valuation of MGN.
Based on the Price/Forward Earnings ratio, MGN is valued cheaper than 100.00% of the companies in the same industry.
MGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.31
Fwd PE 7.76
MGN.OL Price Earnings VS Forward Price EarningsMGN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MGN indicates a rather cheap valuation: MGN is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.24
MGN.OL Per share dataMGN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

MGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y10.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAGNORA ASA

OSL:MGN (3/10/2025, 11:10:59 AM)

22.35

+0.3 (+1.36%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)04-14 2025-04-14
Inst Owners11.34%
Inst Owner ChangeN/A
Ins Owners5.78%
Ins Owner ChangeN/A
Market Cap1.47B
Analysts85
Price Target38.08 (70.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.37
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.61%
Min EPS beat(2)-11.19%
Max EPS beat(2)34.4%
EPS beat(4)1
Avg EPS beat(4)-114.48%
Min EPS beat(4)-379.21%
Max EPS beat(4)34.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)32.68%
Min Revenue beat(2)20.97%
Max Revenue beat(2)44.39%
Revenue beat(4)3
Avg Revenue beat(4)48.53%
Min Revenue beat(4)-37.29%
Max Revenue beat(4)166.04%
Revenue beat(8)5
Avg Revenue beat(8)262.59%
Revenue beat(12)7
Avg Revenue beat(12)294.3%
Revenue beat(16)10
Avg Revenue beat(16)289.83%
PT rev (1m)0%
PT rev (3m)-3.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)14.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)110.97%
Valuation
Industry RankSector Rank
PE 5.31
Fwd PE 7.76
P/S 288.27
P/FCF N/A
P/OCF N/A
P/B 3.17
P/tB 4.76
EV/EBITDA 4.24
EPS(TTM)4.21
EY18.84%
EPS(NY)2.88
Fwd EY12.89%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.08
BVpS7.05
TBVpS4.69
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 95.9%
ROE 129.55%
ROCE 52.69%
ROIC 40.57%
ROICexc 177.59%
ROICexgc N/A
OM 4870.59%
PM (TTM) 11786.27%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y181.44%
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z N/A
F-ScoreN/A
WACC8.41%
ROIC/WACC4.82
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.39%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%1519.54%
EPS Next Y-48.07%
EPS Next 2Y10.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-94.94%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%6503.35%
Revenue Next Year-26.54%
Revenue Next 2Y21.48%
Revenue Next 3Y-24.73%
Revenue Next 5YN/A
EBIT growth 1Y4257.89%
EBIT growth 3YN/A
EBIT growth 5Y57.73%
EBIT Next Year-41.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3596.67%
OCF growth 3YN/A
OCF growth 5YN/A